ロード中...
Trailblazing Precision Oncology for Rare Tumor Subtypes
Molecular Tumor Boards seek to recommend therapeutics to patients based on varying levels of evidence linking specific genetic alterations to treatment response. This commentary highlights the study by Kato and colleagues, which reports the usage of precision medicine approaches in rare and ultra‐ra...
保存先:
| 出版年: | Oncologist |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AlphaMed Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5813755/ https://ncbi.nlm.nih.gov/pubmed/29158369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0494 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|